Mikami et al. and Cai provided evidence that Snail1 may serve as a potential prognostic biomarker and therapeutic target by mediating EMT in clear cell renal cell carcinoma [42,43]. This evidence concerns the gene SNAI1 and clear cell renal carcinoma.